AZNCF - AstraZeneca beats top-line and bottom-line estimates; raises FY24 outlook
2024-07-25 02:07:51 ET
More on AstraZeneca
- AstraZeneca Stock: Upgrading From 'Hold' To 'Buy' Ahead Of Q2 2024 Earnings
- AstraZeneca's Oncology Success: Fueling Future Growth
- AstraZeneca: The Price Upside Is Exhausted For Now (Rating Downgrade)
- Here are Big Pharma’s leading blockbuster makers